Immuneering Corporation SEC filings and other documents

Explore the latest company documents and SEC filings from Immuneering Corporation, including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.

Description

Event date

Documents and forms

2025

Q2 2025

Aug 13, 2025

Earnings release8-K

Quarterly report10-Q

Study Update

Jun 17, 2025

Press release

Slides

Q1 2025

May 5, 2025

Earnings release8-K

Quarterly report10-Q

Oppenheimer 35th Annual Healthcare Life Sciences Conference 2025

Feb 12, 2025

Transcript

Study Result

Jan 7, 2025

Press release

Slides

2024

Q4 2024

Mar 20, 2025

Annual report10-K

Earnings release8-K

Q3 2024

Nov 13, 2024

Earnings release8-K

Quarterly report10-Q

Study Update

Sep 12, 2024

Press release

Q2 2024

Aug 6, 2024

Earnings release8-K

Quarterly report10-Q

Q1 2024

May 7, 2024

Earnings release8-K

Quarterly report10-Q

Study Result

Mar 14, 2024

Press release

2023

Q4 2023

Mar 1, 2024

Annual report10-K

Earnings release8-K

Q3 2023

Nov 9, 2023

Earnings release8-K

Quarterly report10-Q

Q2 2023

Aug 3, 2023

Earnings release8-K

Quarterly report10-Q

Q1 2023

May 4, 2023

Earnings release8-K

Quarterly report10-Q

2022

Q4 2022

Mar 6, 2023

Annual report10-K

Earnings release8-K

Q3 2022

Nov 10, 2022

Earnings release8-K

Quarterly report10-Q

Q2 2022

Aug 10, 2022

Earnings release8-K

Quarterly report10-Q

Q1 2022

May 10, 2022

Earnings release8-K

Quarterly report10-Q

2021

Q4 2021

Mar 10, 2022

Annual report10-K

Earnings release8-K

Q3 2021

Nov 9, 2021

Earnings release8-K

Quarterly report10-Q

Q2 2021

Sep 9, 2021

Earnings release8-K

Quarterly report10-Q